pharmaceuticals
APAC to boost pharmaceutical growth with increased R&D investments
APAC to boost pharmaceutical growth with increased R&D investments
South Korea allocated 5.2% of its GDP to R&D in 2024.
3 days ago
Antibiotics market to grow by $18.22b by 2029
Key drivers include strategic alliances and mergers amongst pharmaceutical firms.
Australia’s pharmaceutical market to see 6% five-year CAGR growth: report
Government measures are expected to challenge pharmaceutical firms.
Biopharmaceutical industry sees mixed performance in 2024: report
Over two-thirds of the top 20 global firms reported a decline in market capitalisation.
Indonesia’s pharma sector to rely on imports despite export boost: report
Imports are forecast to hit $1.6b by 2029, whilst exports are expected to reach $927m.
What’s next for the global heparin market?
It is expected to witness a CAGR of 7.22% through 2028.
UAE pharmaceutical market to be valued at $7.9b by 2029
One driver is the new mandatory health insurance scheme for all private sector employees.
Alzheimer’s disease market across 8MM to hit 19.3b by 2033
DMTs are expected to account for 73.5% of the global market.
Glaucoma market to hit $2.5b in seven major markets by 2033
A report predicts the launch of six late-stage pipeline drugs during this period.
Global testosterone replacement therapy market to rise by $461m by 2029
Its growth is driven by a rising awareness of hypogonadism.
Heart failure market across 7MM to grow at 9.6% CAGR until 2032
One driver is the introduction of drugs targeting unmet needs.
Global pharmaceutical data and analytics market to double by 2028
China represents the largest market for the sector.
Global heparin market to grow by $3.34b by 2028
Key developments include fractionated and low-molecular-weight heparin for thrombosis management.
8MM respiratory syncytial virus prophylaxis market to hit $6.2b by 2030
Thanks to the introduction of new monoclonal antibodies and vaccines.
India’s biotech ambitions face talent and IP challenges
These concerns may lead to a struggle to attract leading drugmakers.
Pharma dose CMOs face slow growth amidst challenging market conditions
The global shortage of generic drugs has worsened over the past year.
Hong Kong pharmaceutical market to be valued at $3b by 2028
However, competition from neighbouring markets poses downside risks.
Most Read
1. Thomson Medical to open second fertility hub 2. Thomson Medical to provide benefits for Great Eastern Life policyholders 3. Global dermatology market to reach $32.98b by 2029 4. SingHealth and Philips ink MoU to advance digital-first healthcare 5. Singapore to establish new communicable diseases agency in AprilResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
She shared how healthcare leaders can balance innovation, governance, and patient outcomes to tackle challenges and drive transformation.
